Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary

Histopathology. 2013 Oct;63(4):534-44. doi: 10.1111/his.12182. Epub 2013 Jul 26.

Abstract

Aims: Mucinous borderline tumours of the ovary are subclassified as intestinal-type (IMBT) and endocervical-like (EMBT), which differ in their clinicopathological features. In this study, we attempted to elucidate characteristics of the mucinous epithelium in each subtype.

Methods and results: The expression of claudin-18, a marker of gastric differentiation, MUCs, CDX2, CK7, CK20, oestrogen receptor (ER), progesterone receptor (PgR), CA-125 and vimentin in IMBTs (n = 54), EMBTs (n = 25) and serous borderline tumours (SBTs) (n = 22) were compared by immunohistochemistry. Claudin-18 positivity was identified in 98% of the IMBTs, whereas only 4% of the EMBTs were claudin-18-positive. Expression of intestinal markers such as CDX2 and MUC2 was relatively infrequent in IMBTs (48% and 33%, respectively). Müllerian-lineage markers such as ER, PgR and vimentin were expressed rarely in IMBTs, while most EMBTs and SBTs were positive for these markers. Hierarchial clustering revealed a close association between EMBTs and SBTs, while IMBTs were clearly separate.

Conclusions: Claudin-18 positivity is a specific phenotype that is characteristic of IMBTs. Frequent and diffuse expression of gastric markers, along with less frequent and usually focal expression of intestinal markers, suggests that IMBTs are essentially composed of gastrointestinal-type mucinous epithelium (gastric-type epithelium with a variable degree of intestinal differentiation).

Keywords: claudin-18; mucinous borderline tumour; ovary.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Claudins / biosynthesis*
  • Cluster Analysis
  • Cystadenocarcinoma, Mucinous / classification
  • Cystadenocarcinoma, Mucinous / metabolism*
  • Cystadenocarcinoma, Mucinous / pathology
  • Cystadenoma, Mucinous / classification
  • Cystadenoma, Mucinous / metabolism*
  • Cystadenoma, Mucinous / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Ovarian Neoplasms / classification
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • CLDN18 protein, human
  • Claudins